- Home
- FBIO vs HCAT Comparison
FBIO vs HCAT Comparison
Compare FBIO & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FBIO | HCAT |
|---|---|---|
| Founded | 2006 | 2008 |
| Country | United States | United States |
| Employees | 78 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.0M | 102.0M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | FBIO | HCAT |
|---|---|---|
| Price | $2.75 | $1.90 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 10 |
| Target Price | ★ $17.00 | $2.53 |
| AVG Volume (30 Days) | 494.2K | ★ 2.6M |
| Earning Date | 05-15-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $311,136,000.00 |
| Revenue This Year | $55.22 | N/A |
| Revenue Next Year | $40.55 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.48 |
| 52 Week Low | $1.75 | $0.96 |
| 52 Week High | $4.53 | $4.13 |
Technical Indicators
Market Signals| Indicator | FBIO | HCAT |
|---|---|---|
| Relative Strength Index (RSI) | 47.30 | 62.81 |
| Support Level | $2.53 | $1.59 |
| Resistance Level | $2.92 | $2.00 |
| Average True Range (ATR) | 0.19 | 0.19 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 8.46 | 74.44 |
Price Performance
Historical ComparisonAbout FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
About HCAT Health Catalyst Inc
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.